News & Events
CVM Updates
Current and past CVM Updates
Outbreaks and Advisories
FDA News
- Harness Trainer Christopher Oakes Sentenced To 3 Years In Federal Doping Case
- FDA Urges Companies to be ’Recall Ready’ to Protect Public Health as Part of Final Guidance for Voluntary Recalls
- FDA Alerts the Public to Potentially Contaminated Products from Family Dollar Stores in Six States
- Horse Doping Drug Supplier Convicted In Manhattan Federal Court
- Former Veterinarian Pleads Guilty to Drug Charges
- Operator of Illegal Veterinary Pharmacy Pleads Guilty
- Prolific Thoroughbred Trainer Sentenced To Five Years In Federal Doping Case
- Court Enjoins California Company from Manufacturing and Distributing Adulterated Sterile Animal Drugs
- Owner Of Illegal Racehorse Doping Websites Sentenced To 18 Months In Prison
- FDA In Brief: FDA Issues a Corporate-Wide Warning Letter to Company Associated with Contaminated Pet Food, Hundreds of Adverse Events
- FDA In Brief: FDA Reminds Industry of Specific Regulations for the Use of Fluorinated Polyethylene in Food Contact Containers
- Owner Of Illegal Racehorse Doping Websites Pleads Guilty In Manhattan Federal Court
- Operator of Racehorse Doping Websites Sentenced to 18 Months in Prison
- FDA Warns Companies Illegally Selling CBD Products
- FDA Approves First-of-its-Kind Intentional Genomic Alteration in Line of Domestic Pigs for Both Human Food, Potential Therapeutic Uses
- Former Supervisor at Long Island Drug Manufacturer Pleads Guilty to Theft of Medical Products
- Department of Justice Files Complaint Against California Company To Stop Distribution of Adulterated Animal Drugs
- FDA Launches New Era of Smarter Food Safety Initiative, Releases Blueprint and Pilot Study
- Remarks by Dr. Hahn on the release of a Blueprint for A New Era of Food Safety
- Animal Health International Sentenced on Federal Misbranding Charge
- FDA Requests Removal of All Ranitidine Products (Zantac) from the Market
CVM is sharing this information with our subscribers because ranitidine is also used in veterinary medicine. - Coronavirus (COVID-19) Update: FDA takes further steps to help mitigate supply interruptions of food and medical products
- FDA Offers Assurance About Food Safety and Supply for People and Animals During COVID-19
- Coronavirus (COVID-19) Update: FDA Helps Facilitate Veterinary Telemedicine During Pandemic
- Medical Glove Conservation Strategies: Letter to Health Care Providers
- Coronavirus (COVID-19) Update: FDA Focuses on Safety of Regulated Products While Scaling Back Domestic Inspections
- Coronavirus (COVID-19) Update: FDA Issues Temporary Policy for FSMA Onsite Audit Requirements
- Surgical Mask and Gown Conservation Strategies - Letter to Healthcare Providers
- FDA Advances Work Related to Cannabidiol Products with Focus on Protecting Public Health, Providing Market Clarity
- FDA Expertise Advancing the Understanding of Intentional Genomic Alterations in Animals
- Collegeville Man Indicted for Scheme to Sell Fraudulent Canine Cancer-Curing Drugs to Pet Owners
- FDA, USDA and EPA announce joint platform to streamline information about agricultural biotechnology products
- FDA warns 15 companies for illegally selling various products containing cannabidiol as agency details safety concerns
- Individual Indicted And Arrested For Illegally Producing And Shipping Adulterated And Misbranded Animal Drugs Without A License
- Statement on FDA’s new report regarding root causes and potential solutions to drug shortages
- Statement on measuring the progress being made through implementing the FDA Food Safety Modernization Act
- FDA Announces Public Meeting to Discuss the New Era of Smarter Food Safety
- FDA warns company marketing unapproved cannabidiol products with unsubstantiated claims to treat cancer, Alzheimer’s disease, opioid withdrawal, pain and pet anxiety
- Federal judge enters consent decree against Arkansas food and medical product grocery warehouse for insanitary conditions
- What You Need to Know (And What We’re Working to Find Out) About Products Containing Cannabis or Cannabis-derived Compounds, Including CBD
- Statement from FDA Associate Commissioner for Regulatory Affairs Melinda K. Plaisier, on agency’s new steps to strengthen the process of initiating voluntary recalls